| Financial Year |
March 31 2023 |
| Monetary Funds |
20,245,924,699.78 |
| Held-for-trading Financial Assets |
56,872,680.00 |
| Notes Receivable |
1,251,284,015.63 |
| Accounts Receivable |
15,951,358,882.70 |
| Advances to Suppliers |
503,399,299.05 |
| Other Receivables |
1,180,528,174.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
218,766,959.00 |
| Inventories |
8,945,104,669.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
556,081,251.66 |
| Other Current Assets |
2,088,861,277.49 |
| Total Current Assets |
55,437,164,388.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,477,174,749.82 |
| Investment Properties |
204,386,354.00 |
| Fixed Assetes |
3,778,120,791.81 |
| Under-construction Projects |
2,066,424,331.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
2,367,712.50 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,570,156,695.05 |
| R&D expenses |
252,326,588.25 |
| Goodwill |
829,473,066.90 |
| Long-Term Deferred and Prepaid Expenses |
168,197,800.47 |
| Deferred Income Tax Assets |
892,498,601.72 |
| Other Non-Current Assets |
228,128,917.53 |
| Sub-Total of Non-Current Assets |
18,221,135,787.49 |
| Total Assets |
73,658,300,175.56 |
| Short-Term Loans |
8,621,019,016.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,454,181,211.74 |
| Accounts Payable |
11,090,426,568.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
987,004,614.51 |
| Taxes Payable |
542,666,926.35 |
| Interest Payable |
-- |
| Dividend Payable |
54,409,701.36 |
| Other payables |
5,216,648,039.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
684,042,672.29 |
| Other Current Liabilities |
508,395,277.21 |
| Sub-Total of Current Liabilities |
32,888,971,001.69 |
| Long-term Loans |
3,136,584,449.64 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,371,964.60 |
| Special Payable |
-- |
| Estimatied Liabilities |
44,035,336.15 |
| Deferred Income Tax Liabilities |
402,904,267.59 |
| Other Non-Current Liabilities |
53,735,795.89 |
| Sub-Total of Non-Current Liabilities |
5,168,378,120.53 |
| Total Liabilities |
38,057,349,122.22 |
| Paid-In Capital(Or Share Stock) |
1,625,790,949.00 |
| Capital Surplus |
10,105,714,430.90 |
| Surplus Reserve |
2,084,386,972.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
20,170,733,807.44 |
| Minority Stockholder's Interest |
1,633,106,030.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
33,967,845,023.03 |
| Owner's Equity（Stockholder's Equity） |
35,600,951,053.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
73,658,300,175.56 |
